Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px
Organisation › Details

Jerini AG (FSE: JI4)

Jerini AG is a pharmaceutical company based in Berlin, Germany focusing on the discovery and development of peptide-based drugs. Having recognized the potential of peptides as natural starting molecules for drug discovery, the company has developed state-of-the-art technologies to identify and transform peptides into drugs. The company's lead product, Icatibant, is currently in Phase III clinical trials for the treatment of hereditary angioedema (HAE). It is estimated that between 1:10,000 and 1:50,000 people worldwide are affected with this disease. Based on its technology platform, Jerini has established several in-house development programs, which address indications within ophthalmology, oncology, and inflammatory therapeutic areas. The most advanced of these programs targets age-related macular degeneration (AMD), the leading cause of vision loss and blindness in people over the age of 55 in developed countries. *

 

Period Start 1994-01-01 established_pre
  Group Takeda (Group)
  Predecessor Jerini Bio Tools GmbH
Product Industry BIOTECH
     
Region Region Berlin
  Country Germany
  Street 130 Invalidenstr.
  City 10115 Berlin
  Tel +49-30-97893-0
    Address record changed: 2020-12-02
     
Basic data Employees D: 101 to 500 (2005-04-20)
  Currency EUR
  Annual sales 13,124,000 (revenues, total, consolidated (2006) 2006-12-31)
  Profit -22,909,000 (2006-12-31)
  Cash 53,700,000 (2007-06-30)
     
    * Document for �About Section�: 
     
   
Record changed: 2020-07-03

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Takeda (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group ChinaBio Partnerting Forum 2021 651x80




» top